Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01293214 · ClinicalTrials.gov registry record · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
A NA study of Limb Amputation and Extremity Amputation, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01293214: Recruiting NA study of Limb Amputation and Extremity Amputation, sponsored by Brigham and Women's Hospital.
NCT01293214 is a NA study of Limb Amputation and Extremity Amputation that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01293214, a NA study of Limb Amputation and Extremity Amputation, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Limb transplantation surgery is the transfer of one or more limbs from a deceased human donor to a patient with single or multiple limb amputation. Hand transplantation is an innovative reconstructive procedure that has the potential to significantly improve the lives of hand amputees. The purpose of this study is to develop the best practices for multiple limb transplantation that will improve the outcomes of future limb transplant recipients.
Primary Outcome
We will undertake an objective evaluation of the results of limb transplantation in an "outcome-oriented" study
Conditions Studied
Interventions
- PROCEDURE Limb transplantation
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-02-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT01293214 shows while recruiting
NCT01293214 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Limb Amputation appearing as the primary indexed condition, and to 1 intervention - of which Limb transplantation is the first listed.
NCT01293214 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01293214 about?
NCT01293214 is a clinical study titled "Vascularized Composite Allotransplantation for Multiple Extremity Amputations". Limb transplantation surgery is the transfer of one or more limbs from a deceased human donor to a patient with single or multiple limb amputation. Hand transplantation is an innovative reconstructive procedure that has the potential to significantly improve the lives of hand amputees. The purpose o...
What is the current status of trial NCT01293214?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2010-02-01. Estimated completion is 2026-12-31.
What conditions does trial NCT01293214 study?
This clinical trial studies the following conditions: Limb Amputation, Extremity Amputation.
What interventions are being tested in trial NCT01293214?
The interventions under investigation include: Limb transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT01293214?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01293214 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01293214's enrollment target sits among peer trials
10 1928th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
- NCT01870752 · 10 participants · NA
Ovarian Tissue Transplantation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI